Label: BRIGHT FUTURE SKIN TINT SPF 25 35 BRONZE- octinoxate, titanium dioxide cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 28, 2023

If you are a consumer or patient please visit this version.

  • Drug Facts

  • Active ingredient

    Octinoxate 7.49%

    Titanium Dioxide 2.28%

    Purpose

    Sunscreen

  • Uses

    • Helps prevent sunburn
    • If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
  • Warnings

    For external use only

    Do not ues 

    • on damaged or broken skin

    When using this product 

    • keep out of eyes. Rinse with water to remove.

    Stop use and ask a doctor if

    • rash occurs

    Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • Apply liberally 15 minutes before sun exposure
    • Reapply at least every 2 hours 
    • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including:
    • Limit time in the sun, especially from 10 a.m. -2 p.m.
    • Wear long-sleeved shirts, pants, hats, and sunglasses
    • Children under 6 months of age: Ask a doctor
  • Other information

    • Protect the product in this container from excessive heat and direct sun
  • Inactive ingredients

    WATER (AQUA), CYCLOPENTASILOXANE, GLYCERIN, ISODODECANE, PENTYLENE GLYCOL, ALCOHOL, DIMETHICONE, VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER, PEG-10 DIMETHICONE, XANTHAN GUM, SORBITAN SESQUIOLEATE, DISTEARDIMONIUM HECTORITE, PHENOXYETHANOL, ACRYLATES/DIMETHICONE COPOLYMER, ALUMINUM HYDROXIDE, ISOSTEARIC ACID, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, BUTYLENE GLYCOL, POLYHYDROXYSTEARIC ACID, SODIUM MYRISTOYL GLUTAMATE, SILICA SILYLATE, PROPYLENE CARBONATE, STEARIC ACID, HYDROLYZED RICE PROTEIN, SODIUM METABISULFITE, BHT, SHEA (BUTYROSPERMUM PARKII) SEEDCAKE EXTRACT, LEMON (CITRUS LIMON) FRUIT EXTRACT, TOCOPHEROL, TITANIUM DIOXIDE (CI 77891), IRON OXIDES (CI 77492), IRON OXIDES (CI 77491), IRON OXIDES (CI 77499).

  • Package Labeling:

    Label9

  • Inner Label

    Bronze

  • INGREDIENTS AND APPEARANCE
    BRIGHT FUTURE SKIN TINT SPF 25 35 BRONZE 
    octinoxate, titanium dioxide cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:31720-709
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE74.9 mg  in 1 mL
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE22.8 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    ISODODECANE (UNII: A8289P68Y2)  
    PENTYLENE GLYCOL (UNII: 50C1307PZG)  
    ALCOHOL (UNII: 3K9958V90M)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)  
    PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    SORBITAN SESQUIOLEATE (UNII: 0W8RRI5W5A)  
    DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    ISOSTEARIC ACID (UNII: X33R8U0062)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    SODIUM MYRISTOYL GLUTAMATE (UNII: AYU7QD893W)  
    PROPYLENE CARBONATE (UNII: 8D08K3S51E)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
    TOCOPHEROL (UNII: R0ZB2556P8)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:31720-709-171 in 1 CARTON08/28/2017
    125 mL in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02008/28/2017
    Labeler - S+ (572406531)